The first GLP-1 medication (liraglutide) was only approved in 2014, and semaglutide wasnt approved until 2017
Retrieved 19 July 2021
You should contact your GP or diabetes care team if you experience: Strong, foul-smelling urine accompanied by pain or burning during urination, increased urinary frequency, or lower abdominal discomfortthese may indicate a urinary tract infection requiring antibiotic treatment according to NICE guidance (NG109)
In summary, whether you are dealing with the infamous Tren cough or following Urs Kalecinskis training plan, adding Semaglutide to your regimen could be the game-changer you need
According to the American Diabetes Association (ADA) Standards of Care, GLP-1 receptor agonists with proven cardiovascular benefit are recommended for many patients with type 2 diabetes who have established cardiovascular disease, with individualized therapy based on patient factors
That said, microdosing is not supported by the same level of clinical evidence as standard dosing protocols